CLASS II Drug recall · Reported 21 Sep 2022 · FDA Enforcement Report

Lisinopril Tablets USP, 10 mg recalled by Lupin Pharmaceuticals

Lupin Pharmaceuticals is recalling Lisinopril Tablets USP, 10 mg, distributed nationwide in the US. The recall was initiated on 13 Sep 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # Q201182, exp. date March 2024
NDC68180-512, 68180-513, 68180-517, 68180-980, 68180-981, 68180-982
UPC0368180513018, 0368180512028, 0368180513032
Quantity recalled11,802 1000-count bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1536-2022
FDA event ID
90859
Recalling firm
Lupin Pharmaceuticals, Baltimore, MD
Manufacturer
Lupin Pharmaceuticals, Inc.
Classification
Class II
Status
Terminated
Recall initiated
13 Sep 2022
FDA classified
15 Sep 2022
Reported
21 Sep 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Foreign Material

Timeline

13 Sep 2022Recall initiated by company
15 Sep 2022Classified by FDA+2 days
21 Sep 2022Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.

Foreign material recalls cover pieces of metal, plastic, glass, wood or other objects that got into the product during processing and could cause injury if eaten.

Product as listed by the FDA

Lisinopril Tablets USP, 10 mg, 1000-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Nagpur- 441 108, India. NDC 68180-980-03

Where it was distributed

Product was distributed to major distributors/wholesalers nationwide.

Nationwide

Questions about this recall

Why was it recalled?

Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.

Which lots are affected?

Lot # Q201182, exp. date March 2024

Where was it sold?

Product was distributed to major distributors/wholesalers nationwide.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Lupin Pharmaceuticals

All 123
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIClobetasol Propionate Cream USP, 0.05% tube recalledClobetasol PropionateLupin PharmaceuticalsOtherNationwide
DrugCLASS IIprednisoLONE Acetate Ophthalmic Suspension recalledPrednisolone AcetateLupin PharmaceuticalsOtherNationwide
DrugCLASS IIGlucagon Emergency Kit for Low Blood Sugar, Glucagon recalledGlucagonLupin PharmaceuticalsPotency & AssayNationwide
DrugCLASS IILiraglutide Injection, 18 mg/ (6 mg/mL) recalledLiraglutideLupin PharmaceuticalsParticulate MatterNationwide
DrugCLASS IISertraline Hydrochloride Tablets USP, 100 mg recalledSertraline HydrochlorideLupin PharmaceuticalsPackaging DefectsNationwide

Other Lisinopril recalls

All 38